Français
ItalianoBond Bristol Myers Squibb 6.25% ( US110122EB03 ) in USD
| Issuer | Bristol Myers Squibb | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  United States
|
||||
| ISIN code |
 US110122EB03 ( in USD )
|
||||
| Interest rate | 6.25% per year ( payment 2 times a year) | ||||
| Maturity | 15/11/2053 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | / | ||||
| Total amount | / | ||||
| Cusip | 110122EB0 | ||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||
| Next Coupon | 15/11/2026 ( In 80 days ) | ||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code US110122EB03, pays a coupon of 6.25% per year. The coupons are paid 2 times per year and the Bond maturity is 15/11/2053 The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code US110122EB03, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code US110122EB03, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||